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To the Editor:
Transcatheter aortic valve replace-
ment (TAVR), an approach developed
for older, frail patients at risk for
open cardiac operations represents
24% of all procedures for the treat-
ment of aortic stenosis in GermanyThe Journaland was recently approved by the
Food and Drug Administration.
Despite the benefits of avoiding
open surgery, TAVR has been associ-
ated with more than tripling the rate
of stroke in inoperable candidates ver-
sus medical therapy controls1 and
a doubling of the stroke rate in high-
risk participants versus high-risk oper-
ative controls.2 The incidence of acute
hyperintensities or ischemia-like le-
sions on diffusion-weighted magnetic
resonance imaging (MRI) of the brain
is double what has been historically
reported for surgical aortic valve re-
placement (AVR).3,4 Furthermore,
the risk of neurologic events in
TAVR patients remains considerably
elevated relative to AVR at 24
months after the procedure.2 Studies
examining outcomes of TAVR
have conducted only gross clinical
evaluations of neurocognitive func-
tion in the relative short term;
the longer-term implications of ‘‘neu-
rologic events’’ and MRI lesions for
older adults after TAVR and many
other cardiovascular procedures have
not been extensively studied.
Although it is intuitive to expect
less-invasive approaches to yield im-
proved outcomes, recent history has
shown that this may not be the case.
The less-invasive ‘‘off-pump’’ ap-
proach to coronary artery bypass graft-
ing was primarily developed to avoid
stroke and cognitive dysfunction
thought to be caused by exposure to
cardiopulmonary bypass, but studies
have not conclusively demonstrated
any real benefit in the incidence of
stroke or postoperative cognitive im-
pairment. The push to implement the
off-pump approach for its perceived
neurologic benefits may have actually
worsened long-term cardiac outcomes
because of the technical challenges as-
sociatedwith revascularizing a beating
heart.5 In light of this historical per-
spective, the lack of mortality benefit
from TAVR over AVR at 1 year,6 in-
creased stroke rate in TAVR patients,
and the increase in ischemic lesions
on MRI after TAVR, we are left toof Thoracic and Cardiovascular Surgerwonder just what real benefit this
less-invasive approach offers.
The largest long-term studies of
neurocognitive outcomes after cardiac
procedures have focused on relatively
younger patients undergoing bypass
grafting and might underestimate the
long-term impact in older adults un-
dergoing different cardiovascular pro-
cedures associated with higher rates of
stroke, cerebral emboli, or greater
cognitive decline. Future research on
neurocognitive outcomes from TAVR
is necessary to determine the neuro-
cognitive risks and benefits associated
with this new procedure as well as the
potential need for adjunctive neuro-
logic interventions.
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